Glen Tetzloff

4.2k total citations · 2 hit papers
31 papers, 3.4k citations indexed

About

Glen Tetzloff is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Glen Tetzloff has authored 31 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 9 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Glen Tetzloff's work include Cholesterol and Lipid Metabolism (10 papers), Drug Transport and Resistance Mechanisms (9 papers) and Diabetes Treatment and Management (5 papers). Glen Tetzloff is often cited by papers focused on Cholesterol and Lipid Metabolism (10 papers), Drug Transport and Resistance Mechanisms (9 papers) and Diabetes Treatment and Management (5 papers). Glen Tetzloff collaborates with scholars based in United States, United Kingdom and France. Glen Tetzloff's co-authors include Harry R. Davis, Lizbeth Hoos, S. Altmann, Michael P. Graziano, Li-Ji Zhu, Xiaorui Yao, Maureen Maguire, Sai Prasad N. Iyer, Andrei Golovko and Ming Zeng and has published in prestigious journals such as Science, Journal of Biological Chemistry and Diabetes.

In The Last Decade

Glen Tetzloff

31 papers receiving 3.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption

2004 1.4k citations S. Altmann, Harry R. Davis et al. Science profile →
Niemann-Pick C1 Like 1 (NPC1L1) Is the Intestinal Phytosterol and Cholesterol Transporter and a Key Modulator of Whole-body Cholesterol Homeostasis

2004 566 citations Harry R. Davis, Li-Ji Zhu et al. Journal of Biological Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Glen Tetzloff United States	20	2.3k	1.2k	1.2k	660	493	31	3.4k
Lizbeth Hoos United States	22	2.8k 1.2×	1.3k 1.0×	1.3k 1.1×	787 1.2×	661 1.3×	30	4.0k
Li-Ji Zhu United States	20	1.8k 0.8×	1.2k 1.0×	848 0.7×	599 0.9×	446 0.9×	23	3.3k
Philippe Costet France	32	3.2k 1.4×	2.1k 1.7×	1.1k 0.9×	631 1.0×	644 1.3×	45	4.5k
Sophie Lestavel France	29	1.7k 0.7×	2.0k 1.6×	763 0.7×	750 1.1×	542 1.1×	62	3.8k
S D Turley United States	18	2.7k 1.1×	1.5k 1.2×	1.3k 1.2×	602 0.9×	475 1.0×	22	4.0k
Ashok K. Batta United States	33	2.6k 1.1×	1.8k 1.5×	1.5k 1.3×	422 0.6×	337 0.7×	81	4.2k
Jiafu Ou United States	12	2.0k 0.9×	1.7k 1.4×	733 0.6×	449 0.7×	499 1.0×	16	3.1k
Martha D. Wilson United States	26	1.4k 0.6×	954 0.8×	554 0.5×	430 0.7×	382 0.8×	42	2.7k
R C Pittman United States	25	2.1k 0.9×	1.3k 1.0×	422 0.4×	1.1k 1.7×	781 1.6×	32	3.8k
Patrick I. Eacho United States	28	1.1k 0.5×	1.3k 1.0×	567 0.5×	519 0.8×	436 0.9×	61	2.7k

Countries citing papers authored by Glen Tetzloff

Since Specialization

Citations

This map shows the geographic impact of Glen Tetzloff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glen Tetzloff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glen Tetzloff more than expected).

Fields of papers citing papers by Glen Tetzloff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glen Tetzloff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glen Tetzloff. The network helps show where Glen Tetzloff may publish in the future.

Co-authorship network of co-authors of Glen Tetzloff

This figure shows the co-authorship network connecting the top 25 collaborators of Glen Tetzloff. A scholar is included among the top collaborators of Glen Tetzloff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Glen Tetzloff. Glen Tetzloff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ason, Brandon, Samnang Tep, Yiming Xu, et al.. (2011). Improved efficacy for ezetimibe and rosuvastatin by attenuating the induction of PCSK9. Journal of Lipid Research. 52(4). 679–687. 36 indexed citations

Vassileva, Galya, Weiwen Hu, Lizbeth Hoos, et al.. (2010). Gender-dependent effect of Gpbar1 genetic deletion on the metabolic profiles of diet-induced obese mice. Journal of Endocrinology. 205(3). 225–232. 68 indexed citations

Zheng, Shuqin, Lizbeth Hoos, John A. Cook, et al.. (2008). Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice. European Journal of Pharmacology. 584(1). 118–124. 145 indexed citations

Davis, Harry R., et al.. (2008). Cholesterol homeostasis by the intestine: Lessons from Niemann-Pick C1 Like 1 [NPC1L1). Atherosclerosis Supplements. 9(2). 77–81. 34 indexed citations

Hong, Lan, Lizbeth Hoos, Li Liu, et al.. (2008). Lack of FFAR1/GPR40 Does Not Protect Mice From High-Fat Diet–Induced Metabolic Disease. Diabetes. 57(11). 2999–3006. 104 indexed citations

Vassileva, Galya, Andrei Golovko, Susan J. Abbondanzo, et al.. (2006). Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. Biochemical Journal. 398(3). 423–430. 229 indexed citations

Kowalski, Timothy J., Brian D. Spar, Mandy J. Maguire, et al.. (2005). Transgenic overexpression of neuromedin U promotes leanness and hypophagia in mice. Journal of Endocrinology. 185(1). 151–164. 59 indexed citations

Iyer, Sai Prasad N., Xiaorui Yao, James H. Crona, et al.. (2005). Characterization of the putative native and recombinant rat sterol transporter Niemann-Pick C1 Like 1 (NPC1L1) protein. Biochimica et Biophysica Acta (BBA) - General Subjects. 1722(3). 282–292. 71 indexed citations

Davis, Harry R., Li-Ji Zhu, Lizbeth Hoos, et al.. (2004). Niemann-Pick C1 Like 1 (NPC1L1) Is the Intestinal Phytosterol and Cholesterol Transporter and a Key Modulator of Whole-body Cholesterol Homeostasis. Journal of Biological Chemistry. 279(32). 33586–33592. 566 indexed citations breakdown →

10.

Altmann, S., Harry R. Davis, Li-Ji Zhu, et al.. (2004). Niemann-Pick C1 Like 1 Protein Is Critical for Intestinal Cholesterol Absorption. Science. 303(5661). 1201–1204. 1393 indexed citations breakdown →

11.

Altmann, S., Harry R. Davis, Xiaorui Yao, et al.. (2002). The identification of intestinal scavenger receptor class B, type I (SR-BI) by expression cloning and its role in cholesterol absorption. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1580(1). 77–93. 124 indexed citations

12.

Davis, Harry R., Douglas S. Compton, Lizbeth Hoos, & Glen Tetzloff. (2001). Ezetimibe, a Potent Cholesterol Absorption Inhibitor, Inhibits the Development of Atherosclerosis in ApoE Knockout Mice. Arteriosclerosis Thrombosis and Vascular Biology. 21(12). 2032–2038. 180 indexed citations

13.

Heek, Margaret van, et al.. (2000). The potent cholesterol absorption inhibitor, ezetimibe, ablates hypercholesterolemia and hypertriglyceridemia in a model of combined hyperlipidemia. Atherosclerosis. 151(1). 132–132. 1 indexed citations

14.

Chintala, Madhu, et al.. (1998). Disparate effects of thrombin receptor activating peptide on platelets and peripheral vasculature in rats. European Journal of Pharmacology. 349(2-3). 237–243. 9 indexed citations

15.

Chiu, Peter J.S., Glen Tetzloff, Carolyn Foster, Madhu Chintala, & Edmund J. Sybertz. (1997). Characterization of in vitro and in vivo platelet responses to thrombin and thrombin receptor-activating peptides in guinea pigs. European Journal of Pharmacology. 321(1). 129–135. 7 indexed citations

16.

Chiu, Peter J.S., et al.. (1997). Inhibition of platelet adhesion and aggregation by E4021, a type V phosphodiesterase inhibitor, in guinea pigs. Naunyn-Schmiedeberg s Archives of Pharmacology. 355(4). 463–469. 12 indexed citations

17.

Chiu, Peter & Glen Tetzloff. (1993). EDRF(NO)-mediated modulation of collagen-induced platelet accumulation in rat pulmonary microcirculation. Journal of Biomedical Science. 1(1). 43–48. 12 indexed citations

18.

Chiu, Peter J.S., Glen Tetzloff, Ho-Sam Ahn, & Edmund J. Sybertz. (1988). Effects of BRL 34915, a putative K channel opener, on transmembrane 45Ca movements in rabbit aortic smooth muscle. European Journal of Pharmacology. 155(3). 229–237. 14 indexed citations

19.

Chiu, P. J. S., Glen Tetzloff, Hye Sook Ahn, & Edmund J. Sybertz. (1988). Comparative Effects of Vinpocetine and 8-Br-Cyclic GMP on the Contraction and 45Ca-Fluxes in the Rabbit Aorta. American Journal of Hypertension. 1(3 Pt 1). 262–268. 32 indexed citations

20.

Chiu, Peter, Glen Tetzloff, & Edmund J. Sybertz. (1986). A post-calcium site of action for HA1004, a novel vasculorelaxant. Life Sciences. 39(3). 255–261. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact